Prognostic factors in NSCLC. Recent experiences

This publication has 15 references indexed in Scilit:

• Correlation of Expression of H/Le^Y/Le^BAntigens with Survival in Patients with Carcinoma of the Lung
  New England Journal of Medicine, 1992
• Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
  European Journal of Cancer and Clinical Oncology, 1991
• Presence of a Potent Transcription Activating Sequence in the p53 Protein
  Science, 1990
• K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
  New England Journal of Medicine, 1990
• The p53 proto-oncogene can act as a suppressor of transformation
  Cell, 1989
• Monoclonal antibody 123C3 in lung tumour classification Immunohistology of 358 resected lung tumours
  Molecular and Cellular Probes, 1988
• Mutational Activation of the K-rasOncogene
  New England Journal of Medicine, 1987
• Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
  Journal of Clinical Oncology, 1986
• Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.
  Journal of Clinical Oncology, 1984
• Survival with inoperable lung cancer.An integration of prognostic variables based on simple clinical criteria
  Cancer, 1977